Line 660: |
Line 660: |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Associate Editor?? | + | |'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor?? |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |T-cell Prolymphocytic Leukemia||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |T-cell Large Granular Lymphocytic Leukemia||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Chronic Lymphoproliferative Disorder of NK Cells||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Aggressive NK-cell Leukemia||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Severe Mosquito Bite Allergy||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Adult T-cell Leukemia/Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Enteropathy-Associated T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Hepatosplenic T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Mycosis Fungoides||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Sézary Syndrome||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Lymphomatoid Papulosis||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin''''' ||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Angioimmunoblastic T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Follicular T-cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor?? |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Nodular Sclerosis Classic Hodgkin Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Mixed Cellularity Classic Hodgkin Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Lymphomas Associated with HIV Infection||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Non-Destructive Post-Transplant Lymphoproliferative Disorders ||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Polymorphic Post-Transplant Lymphoproliferative Disorders ||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | ''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Monomorphic B-cell PTLD||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Monomorphic T/NK-cell PTLD||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Histiocytic Sarcoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Langerhans Cell Histiocytosis||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Langerhans Cell Sarcoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Indeterminate Dendritic Cell Tumour||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Interdigitating Dendritic Cell Sarcoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Follicular Dendritic Cell Sarcoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Fibroblastic Reticular Cell Tumor||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Disseminated Juvenile Xanthogranuloma||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | |Erdheim-Chester Disease||Disease|| || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| || | + | | || || || |
| | | | | |
| | | | | |
| |} | | |} |